INTRODUCTION
============

The most prevalent technique for body contouring has been liposuction. Recently, many methods for obesity treatment have been introduced worldwide and many case reports have been published. Phosphatidylcholine (PPC) and deoxycholate (DCA) compound is one of them, and was introduced for efficiently reducing fat tissue without serious complications.

PPC is composed primarily of lecithin, which is a main constituent of beans. This substance prevents fatty accumulation and is used to treat liver failure induced by fatty liver, myocardial ischemia, cerebrovascular diseases, and dementia. It has also been recently introduced for lipolysis for obesity treatment in the United States, Europe, and South America. Deoxycholate is used to produce a detergent effect so that the PPC can be well-dissolved.

Partial lipolysis performed with PPC and DCA injection is more efficient, effective, and non-invasive technique than the liposuction and dermolipectomy that were previously performed. Some doctors are currently using this technique for treating buffalo hump, lipoma, and xanthelasma related to human immunodeficiency virus and some private clinics are using it for local fat removal of the thighs, flanks, neck, and face \[[@B1]-[@B7]\].

Although the interest in PPC is currently increasing, the study of of the lipolysis effect of PPC has not been thoroughly studied. Some studies about lipolysis have been reported using a rabbit model but their results areinconclusive \[[@B8]-[@B10]\].

In this article, the authors report a preclinical study on the histologic effect of PPC injection to the adipose tissue in a rat model and establish a new rat model for such research.

METHODS
=======

Fifteen male Sprague-Dawley rats weighing 280 to 300 g were raised under controlled conditions for one week, and their bilateral inguinal areas were used for the experiment. Flaps were elevated at the bilateral inguinal fat pads of the rats, with one side used as the experimental group and the other as the control group. A 2-cm incision was made at the bilateral inguinal area and the inguinal fat pad was exposed ([Fig. 1](#F1){ref-type="fig"}). Communicating branches between the skin and the fat tissue were all clamped and coagulated. This resulted in an island flap composed of the inguinal fat pad with the deep inferior epigastric artery as the only vascular pedicle. Inguinal fat pad anatomy is relatively stationary, ensuring a less complicated dissection in which the environment did not fluctuate in this study. The left inguinal fat pads were used as a control group and 1 mL saline was injected. On the right side, 0.8 mL of the PPC/DCA compound and 0.2 mL of a lidocaine mixture were injected for the experimental group. The components of the PPC solution used in this experiment are described in [Table 1](#T1){ref-type="table"}. After four days, the rats were euthanized and the tissues were fixed with formalin and embedded into a paraffin block for histologic examination ([Fig. 2](#F2){ref-type="fig"}). Histologic examination was performed by well-trained pathologists in double-blind fashion. The pathologists had no information about which group the sample they were examining was from. Four factors were examined in each sample: the quantity of normal fat, fat necrosis, inflammatory activity, and stage of fibrosis. Each category was scored in semi-quantitative fashion into one of five grades according to the percentage in one microscopic field (×100): grade 0 (0%), grade 1 (\<25%), grade 2 (26% to 50%), grade 3 (51% to 75%), and grade 4 (76% to 100%). Hematoxylin and eosin staining was used in evaluating the inflammatory status and Masson\'s trichrome staining was helpful in evaluating the necrotic status of the samples. Statistical analysis was powered by the PASW statistics ver. 18.0 (IBM Inc., New York, NY, USA) and the Wilcoxon signed-rank test was utilized for determining significance.

RESULTS
=======

There was a statistically significant histologic difference between the saline injection group and PPC/DCA injection group ([Fig. 3](#F3){ref-type="fig"}). In the samples from the saline-injected group that were stained with hematoxylin-eosin, normal fat tissue was maintained overall with a mean score of 3.93/4. Also, almost no inflammatory cells were recruited, with a mean score of 0.67/4. In the necrosis analysis, with a mean score of 0.07/4, we could see that saline did not cause the fat cells to necrotize ([Fig. 4](#F4){ref-type="fig"}). On the other hand, the PPC/DCA injected group showed much more inflammatory activity with a mean value of 3.2/4 and a smaller volume of normal fat than the saline-injected group with a mean value of 2.07/4. Regarding necrosis, significantly more cells in the experimental group resulted in necrosis than in the saline-injected group, showing a mean value of 2.07/4 ([Fig. 5](#F5){ref-type="fig"}). Fibrosis was examined under Masson\'s trichrome staining and in the saline-injected group, minimal fibrosis was found with a mean value of 0.6/4 ([Fig. 6](#F6){ref-type="fig"}). In the PPC/DCA-injected group, however, a significant amount of fibrosis was shown, as the mean value jumped up to 2.13/4 ([Fig. 7](#F7){ref-type="fig"}). All of the values showed statistical significance when analyzed by the Wilcoxon signed-rank test following the semi-quantitative scoring system (P\<0.01).

DISCUSSION
==========

Traditionally accepted treatments for obesity were diet control, exercise, and behavior therapy, and drug usage is also increasing. Obesity is now considered to be a disease and at the same time an important risk factor for hypertension, diabetes mellitus, and cardiovascular diseases. It is obvious that treating obesity may help in prophylaxis of these related diseases and their complications, but this should be clearly distinguished from body contour correction, which reduces the fat tissue of a specific part of the body. Body contour correction can sometimes reduce the risk factors of obesity but more importantly, it increases patients with their body image. A typical example of body contouring is liposuction. It is an invasive procedure that is performed under general anesthesia and is relatively expensive. Moreover, fatal complications may take place, such as fat embolism and sepsis, although the incidence is very rare. For this reason, many new body contouring procedures has been recently introduced for local fat tissue reduction. Although many of these procedures are available to the public, few of them have been properly tested for their efficacy and safety for use in the reduction of adipose cells and tissues.

Lately, a drug composed of PPC, which is extracted from soybean oil, was introduced. PPC is mainly composed of lecithin and is an important phospholipid in the cell membrane. This substance influences triglyceride metabolism including cholesterol, and increases the solubility of cholesterol, which may cause changes in the composition of fat deposits and prevents plaque aggregation of adipose tissue. As a result of this pharmacologic mechanism, PPC is currently used as a medicine for many diseases such as lipid atheroma, hypercholesterolemia, fat embolism, fatty deposits, atherosclerotic plaque, metal disturbances, and liver cirrhosis caused by drugs or alcohol \[[@B11]\].

PPC has gained some popularity in recent several years as a prevalent form of injection lipolysis material and has become popular in the United States, Europe, and South America for this purpose \[[@B12]\]. Mesotherapy is also an injection form of lipolysis which is currently popular, but it differs from PPC in that the former is a \"size-reducing\" procedure whereas the latter destroys the adipose cells. This is why the brand names for this therapy include the Lipodissolve and fat-away.

PPC was first introduced into medicine in the 1960s. It was firstly used as a treatment option for cardiovascular accident, cerebrovascular diseases, and dementia prophylaxis. It was in the 1980s when PPC usage was initially reported for aesthetic purposes at the International Convention of Mesotherapy in Paris. In the convention, Doctor Sergio Magguiori from Italy first announced the original use of PPC for its lipolytic effect on eyelid xanthelasma. In the mid-1990\'s, a Brazilian dermatologist, Doctor Patricia Rittes \[[@B13]\], published a PPC usage manual for removing infraorbital fat tissue. This initiated the invention of many new partial lipolysis techniques worldwide, and clinical studies are now in progress in the US under US Food and Drug Administration approval. In 2006, Doctor Franz Hasengschwandtner \[[@B14]\] from Austria published his findings that 441 patients who received PPC injections all experienced a lipolysis effect. He described in his article that this PPC injection therapy is very safe, as all but 6 patients who were enrolled in his study were satisfied with their results. Likewise, PPC injection as lipolysis treatment is becoming a matter of interest worldwide \[[@B13],[@B15],[@B16]\].

The efficacy of PPC is generally accepted, but there have been relatively few good studies about the safety of the treatment, although few complications have been reported. Also, some recent studies suggest that DCA has some effect in lipo-destruction *in vitro* \[[@B17]-[@B20]\]. This remains a question to be addressed in future research.

The present experiment on the lipolytic effect of PPC/DCA in a rat model has provided a useful clinical basis for the efficacy of PPC/DCA and a foundation for a future clinical trial. The rat inguinal fat pad model we proposed for the study of lipolysis may also become a useful tool as it is anatomically orderly and simple to manipulate.

In conclusion, the PPC/DCA-injected group and the control group had significantly different quantities of normal fat tissue, inflammation, necrosis, and fibrosis in a rat inguinal fat pad model. This suggests the injection of PPC/DCA affects the fat tissue component histologically and this can be the clinical basis for additional safety research and for a future clinical trial.
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![Inguinal fat pad of a rat\
Elevation of pedicled inguinal fat pad of a rat.](aps-39-452-g001){#F1}

![Gross photo of fat tissue\
Gross photo of inguinal fat pads after 4 days of experiments. PPC, phosphatidylcholine.](aps-39-452-g002){#F2}

![Result of the experiment\
Comparison of normal fat distribution, inflammation, necrosis, and fibrosis between saline-injected fat tissue and phosphatidylcholine (PPC)/deoxycholate injected fat tissue. All categories showed significant differences (P\<0.01).](aps-39-452-g003){#F3}

![Microscopic view of saline injected fat tissue\
Microscopic examination of H&E stained fat tissue, ×100 magnification of saline injected fat tissue.](aps-39-452-g004){#F4}

![Microscopic view of PPC/DCA injected fat tissue\
Microscopic examination of H&E stained fat tissue, ×100 magnification of PPC-injected fat tissue. A histiocytic and giant cell reaction are seen with fat necrosis. Neutrophilic infiltrate is also seen, indicating an inflammatory response. PPC, phosphatidylcholine; DCA, deoxycholate.](aps-39-452-g005){#F5}

![Microscopic view of saline injected fat tissue\
Microscopic examination of Masson\'s trichrome-stained fat tissue, ×100 magnification of saline-injected fat tissue.](aps-39-452-g006){#F6}

![Microscopic view of PPC/DCA injected fat tissue\
Microscopic examination of Masson\'s trichrome-stained fat tissue, ×100 magnification of PPC-injected fat tissue. PPC, phosphatidylcholine; DCA, deoxycholate.](aps-39-452-g007){#F7}
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The component of phosphatidylcholine (PPC)/deoxycholate solution used in this experiment
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^a)^Produced by Samchundang Pharmaceutics Inc.
